Altimmune Inc ALT

$2.14 +0.04 (1.90%)

Valuation

Market cap
408,488,000
Revenue TTM
$40,000
Net income TTM
$-88,090,000
PE ratio
0.00
Forward PE
—
Profit margin
-220,225.00%
Debt to equity
0.12

Trading

Volume
2,672,400
Avg volume
3,826,286
Day's range
$2.10 – $2.18
Shares out
194,518,000
Stochastic %K
41%
Beta
0.06
Analysts
Strong Sell
Price target
$14.50

Price

Company profile

Altimmune, Inc., a late clinical stage biopharmaceutical company, focuses on developing novel therapies for serious liver diseases. Its lead product candidate is pemvidutide, a GLP-1/glucagon dual receptor agonist, which is in Phase 3 clinical trial for the treatment of metabolic dysfunction-associated steatohepatitis, alcohol use disorder, and alcohol-associated liver disease. The company was founded in 1997 and is...

Show more

Altimmune, Inc., a late clinical stage biopharmaceutical company, focuses on developing novel therapies for serious liver diseases. Its lead product candidate is pemvidutide, a GLP-1/glucagon dual receptor agonist, which is in Phase 3 clinical trial for the treatment of metabolic dysfunction-associated steatohepatitis, alcohol use disorder, and alcohol-associated liver disease. The company was founded in 1997 and is headquartered in Gaithersburg, Maryland.

Industry
Biotechnology
Sector
Healthcare
Phone
240 654 1450
Website
https://altimmune.com
Address
910 Clopper Road, Suite 201S, Gaithersburg, United States

Latest news

Stocktwits

spaarrow1 Oct 30, 2:45 PM
$ALT why take a loan on 10 m usd IF they have 400 m usd?
0 replies
Bealsta8 Oct 30, 2:45 PM
$ALT very
0 replies
JackedNicholson Oct 30, 2:22 PM
$ALT today my F&F would be still +2%… lol
1 replies
LeaperM75 Oct 30, 2:16 PM
$ALT AASLD next week! What's under the hood, Jerome?!
0 replies
BackWatchonly Oct 30, 2:10 PM
$ALT starter today!
3 replies
Hatrak1 Oct 30, 2:06 PM
$ALT Lap them up and let's get on with it you bunch of drama queens ! 😁
0 replies
Turribull Oct 30, 1:59 PM
$ALT
0 replies
Prairiedog54 Oct 30, 1:59 PM
$ALT
0 replies